Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human interferon α2b spray in pediatric herpangina
CTR20233836Phase 2Completed
- Sponsor
- Beijing Kawin Technology Share-Holding Co., Ltd.
- Start
- Nov 2023
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of interferon alfa-2b in herpangina, sponsored by Beijing Kawin Technology Share-Holding Co., Ltd.. Started Nov 2023; status: completed.
02
Drugs
interferon alfa-2b
03
Conditions
herpangina
Beyond the preview
Go deeper on CTR20233836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233836.